Economics of employer-sponsored workplace vaccination to prevent pandemic and seasonal influenza

Bruce Y. Lee, Rachel R. Bailey, Ann E. Wiringa, Abena Afriyie, Angela R. Wateska, Kenneth J. Smith, Richard K. Zimmerman

Research output: Contribution to journalArticle

Abstract

Employers may be loath to fund vaccination programs without understanding the economic consequences. We developed a decision analytic computational simulation model including dynamic transmission elements that estimated the cost-benefit of employer-sponsored workplace vaccination from the employer's perspective. Implementing such programs was relatively inexpensive (<$35/vaccinated employee) and, in many cases, cost saving across diverse occupational groups in all seasonal influenza scenarios. Such programs were cost-saving for a 20% serologic attack rate pandemic scenario (range: -$15 to -$995) per vaccinated employee) and a 30% serologic attack rate pandemic scenario (range: -$39 to -$1,494 per vaccinated employee) across all age and major occupational groups.

Original languageEnglish (US)
Pages (from-to)5952-5959
Number of pages8
JournalVaccine
Volume28
Issue number37
DOIs
StatePublished - Aug 1 2010
Externally publishedYes

Keywords

  • Influenza
  • Vaccination
  • Workplace

ASJC Scopus subject areas

  • Molecular Medicine
  • Immunology and Microbiology(all)
  • veterinary(all)
  • Public Health, Environmental and Occupational Health
  • Infectious Diseases

Fingerprint Dive into the research topics of 'Economics of employer-sponsored workplace vaccination to prevent pandemic and seasonal influenza'. Together they form a unique fingerprint.

  • Cite this

    Lee, B. Y., Bailey, R. R., Wiringa, A. E., Afriyie, A., Wateska, A. R., Smith, K. J., & Zimmerman, R. K. (2010). Economics of employer-sponsored workplace vaccination to prevent pandemic and seasonal influenza. Vaccine, 28(37), 5952-5959. https://doi.org/10.1016/j.vaccine.2010.07.003